Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Dogwood (Not Specified) has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Anthocyanin-rich fruit extracts lose colour and constituent integrity to oxidation during storage. Ascorbate competes for the oxidant and slows that loss, which is why fruit powders are frequently formulated with it. The relationship is chemical stabilisation in the product as much as anything physiological. It is not evidence of a combined effect in a person.
Polyphenolic tannins bind ferric iron tightly and precipitate it out of solution before the intestinal transporter can act. This is the same well-documented mechanism by which tea reduces iron uptake from a meal. Anyone taking iron for low iron status should separate it from a tannin-rich botanical by two hours or more. The effect size depends on how much tannin the specific preparation carries, which for an unspecified dogwood is unknown.
Different polyphenol classes have different one-electron reduction potentials, so a mixture buffers oxidative stress across a broader window than an isolate. The dogwood fruit contributes anthocyanins and iridoid glycosides to that mix. The reasoning is chemical and cell-level. No human study of the combination exists.
Iridoid glycosides pass the small intestine largely intact and are deglycosylated by bacterial beta-glucosidases in the colon. The released aglycones are what enters circulation, often after further modification. This is standard glycoside pharmacokinetics and explains why plasma levels of the parent glycoside are low after an oral dose. It is a mechanism, not a tested product pairing.
Colonic bacteria carry the beta-glucosidase activity that liberates aglycones from plant glycosides. Two people taking the same dogwood extract can generate quite different metabolite profiles depending on their microbiome. That makes conversion capacity a real source of variation in response. It does not follow that adding a probiotic strain improves any outcome.
Both barks appear in nineteenth century North American materia medica for overlapping traditional uses, dogwood bark having been employed when cinchona was unavailable. That shared history explains why they turn up in the same formulas. It is a traditional pairing rather than a pharmacological one, and willow bark carries salicylates that dogwood does not. Combining two tannin-heavy barks also compounds the mineral binding issue.
Nothing specific on file for Dogwood (Not Specified). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.